In addition, it is well known that estrogen receptor (ER)-negative breast cancer is more sensitive to taxanes than ER-positive breast cancer, and one possible reason is that ER regulates Bcl-2-induced taxane resistance in breast cancer cells by inhibiting apoptotic cell death [103]. Here, BCL2 is linked to breast carcinoma.